Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
FPINT_SITE |
By site support type: Direct Service Delivery (DSD): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services |
2015 |
502 |
FPINT_SITE |
By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported HIV service delivery points |
2015 |
628 |
FPINT_SITE |
Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services |
2015 |
502 |
FPINT_SITE |
Service delivery type: Clinical |
2015 |
502 |
FPINT_SITE |
Sum of Numerator Site Support Type disaggregates |
2015 |
502 |
FPINT_SITE |
Sum of Service Delivery Type disaggregates |
2015 |
502 |
FPINT_SITE |
Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment |
2015 |
628 |
FPINT_SITE_den |
Sum of Denominator Site Support Type disaggregates |
2015 |
628 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2015 |
5,444 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2015 |
5,443 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2015 |
104,677 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2015 |
5,228 |
HTS_TST |
Aggregated Age/sex: <15 Female |
2015 |
5,444 |
HTS_TST |
Aggregated Age/sex: <15 Male |
2015 |
5,443 |
HTS_TST |
Aggregated Age/sex: 15+ Female |
2015 |
104,677 |
HTS_TST |
Aggregated Age/sex: 15+ Male |
2015 |
5,228 |
HTS_TST |
By Test Result: Negative |
2015 |
114,058 |
HTS_TST |
By Test Result: Negative |
2015 |
114,058 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
120,792 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
120,792 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
10,887 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2015 |
10,887 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
109,905 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2015 |
109,905 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
120,792 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2015 |
120,792 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
120,792 |
HTS_TST |
Sum of Test Result disaggregates |
2015 |
120,792 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
6,734 |
HTS_TST_POS |
By Test Result: Positive |
2015 |
6,734 |
PMTCT_ARV |
Life-long ART (including Option B+) |
2015 |
5,445 |
PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
5,731 |
PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
5,444 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2015 |
869 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2015 |
4,576 |
PMTCT_ARV |
Sum of New and Current disaggregates |
2015 |
5,445 |
PMTCT_ARV |
Sum of Regimen Type disaggregates |
2015 |
5,445 |
PMTCT_ARV_NGI |
Life-long ART (including Option B+) |
2015 |
5,445 |
PMTCT_ARV_NGI |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
5,731 |
PMTCT_ARV_NGI |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
5,444 |
PMTCT_ARV_NGI |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2015 |
869 |
PMTCT_ARV_NGI |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2015 |
4,576 |
PMTCT_ARV_NGI |
Sum of New and Current disaggregates |
2015 |
5,445 |
PMTCT_ARV_NGI |
Sum of Regimen disaggregates |
2015 |
5,445 |
PMTCT_EID |
By infants who received a virologic test within 2 months of birth |
2015 |
2,177 |
PMTCT_EID |
By infants who received their first virologic HIV test between 2 and 12 months of age |
2015 |
8,710 |
PMTCT_EID |
By infants with a positive virologic test result within 12 months of birth |
2015 |
708 |
PMTCT_EID |
Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) |
2015 |
11,924 |
PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2015 |
10,887 |
PMTCT_EID |
Sum of Infant Age disaggregates |
2015 |
10,887 |
PMTCT_SITE |
By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women |
2015 |
597 |
PMTCT_SITE |
By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) |
2015 |
628 |
PMTCT_SITE |
Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women |
2015 |
597 |
PMTCT_SITE |
Sum of Numerator Support Type disaggregates |
2015 |
597 |
PMTCT_SITE |
Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) |
2015 |
628 |
PMTCT_SITE_den |
Sum of Denominator Support Type disaggregates |
2015 |
628 |
PMTCT_STAT |
By: Known positives at entry |
2015 |
1,433 |
PMTCT_STAT |
By: Number of new positives identified |
2015 |
4,298 |
PMTCT_STAT |
Number of new ANC and L&D clients |
2015 |
106,695 |
PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2015 |
104,561 |
PMTCT_STAT |
Sum of Positives Status disaggregates |
2015 |
5,731 |
PMTCT_STAT_NGI |
By: Known positives at entry |
2015 |
1,433 |
PMTCT_STAT_NGI |
By: Number of new positives identified |
2015 |
4,298 |
PMTCT_STAT_NGI |
Number of new ANC and L&D clients |
2015 |
106,695 |
PMTCT_STAT_NGI |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2015 |
104,561 |
PMTCT_STAT_NGI |
Sum of Positives Status disaggregates |
2015 |
5,731 |
SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
628 |
SITE_SUPP |
By program area/support type: HTC Direct Service Delivery (DSD) |
2015 |
628 |
SITE_SUPP |
By program area/support type: PHDP/Family Planning & Integration Technical Assistance-only (TA) |
2015 |
628 |
SITE_SUPP |
By program area/support type: PMTCT Direct Service Delivery (DSD) |
2015 |
628 |
SITE_SUPP |
By program area/support type: TB/HIV Technical Assistance-only (TA) |
2015 |
628 |
SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
628 |
TX_CURR |
Age/Sex: 15+ Female |
2015 |
4,575 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
4,575 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
4,575 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
4,575 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
4,575 |
TX_CURR_NGI |
Age/Sex: 15+ Female |
2015 |
30,890 |
TX_CURR_NGI |
Aggregated Age/Sex: 15+ Female |
2015 |
30,890 |
TX_CURR_NGI |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
43,984 |
TX_CURR_NGI |
Sum of Age/Sex disaggregates |
2015 |
43,984 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex 15+ |
2015 |
42,289 |
TX_CURR_NGI |
Sum of Aggregated Age/Sex disaggregates |
2015 |
43,984 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2015 |
4,575 |
TX_NEW |
By Age/Sex: 15-19 Female |
2015 |
915 |
TX_NEW |
By Age/Sex: 20-24 Female |
2015 |
1,601 |
TX_NEW |
By Age/Sex: 25-49 Female |
2015 |
2,059 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
4,575 |
TX_NEW |
Pregnancy status |
2015 |
4,575 |
TX_NEW |
Sum of Age/Sex disaggregates |
2015 |
4,575 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2015 |
4,575 |